Behçet Syndrome (BS) Overview

Slides:



Advertisements
Similar presentations
BEHÇET’S SYNDROME (BS)
Advertisements

Difficult-to-Treat Psoriasis: Gaining Control of Palmoplantar and Nail Psoriasis.
(Occulo-oral-genital syndrome)
Internist, Rheumatologist
This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the US, and data that were.
Moderate-to-Severe Asthma Management
Familial Chylomicronemia Syndrome
Clinical Trials in IBD.
Psoriatic Arthritis.
This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the United States.
Demystifying Idiopathic Pulmonary Fibrosis
Essential Updates in Atopic Dermatitis:
Effective Management of Psoriatic Arthritis: Tailoring Treatments
Goals of Therapy for Patients With UC
Chronic Rhinosinusitis
Charting Progress in MS Diagnosis and Treatment for Today and Tomorrow
The Latest Data on Oral Prostacyclin Therapy in PAH
From Conference to Practice: Big Data in Psoriasis
Medication Nonadherence in Gout
Updates in Management of Atopic Dermatitis From Real Patient Cases
Continuing the Advances in Relapsed/Refractory CLL: New Data, New Paradigms.
Advances in Dry Eye.
Program Goals. Program Goals What is Atopic Dermatitis?
Comparing Treatment Alternatives in Ankylosing Spondylitis
Therapeutic Strategies in the Management of Mild-to-Moderate Atopic Dermatitis.
The Resurgence of Topical Treatments Across a Spectrum of Psoriasis
Chronic Idiopathic Urticaria
Addressing Disease Burden in Asthma
BEHÇET’S SYNDROME (BS)
Multidisciplinary Perspectives on Interstitial Lung Diseases
Next-Gen Psoriasis Therapies:
Evaluating Next-Generation BTK Inhibitors
Gene Therapy: Past, Present, and Future
Emerging Atopic Dermatitis Treatments:
Tackling Atopic Dermatitis
Ask the Experts.
Immunotherapy for cSCC
Evolving Treatment Landscape for PsA
Perspectives on the Impact of Inflammation in OA
Advancing the Treatment of IBD With Biologics
When Is Biologic Therapy Appropriate for HS?
Improving Outcomes in Psoriatic Arthritis
Current and Emerging Strategies for Management of Moderate-to-Severe Atopic Dermatitis.
When to Start and What to Use
Immune Checkpoint Inhibitors in Lung Cancer
Advancing Patient Care in RA
Understanding and Addressing the Needs of Patients With AD
The Multifaceted Nature of Psoriasis Addressing Patients' Needs
Challenges in Severe Asthma
EGPA.
Ask the Psoriasis Expert
Patient Questions and Expert Answers in Psoriasis:
Diagnosis, Evaluation, and Therapy for Severe Refractory Eosinophilic Asthma.
Update on the Management of Atopic Dermatitis
Essential Updates for PsA: A Complex Disease to Manage
Assessing the Burden of Hyperkalemia
(Occulo-oral-genital syndrome)
HAE Prophylaxis.
Assessing the Burden of Hyperkalemia
perforation of an ileal ulcer a patient with Behçet’s disease
Optimizing Treatment of Refractory Gout
Tardive Dyskinesia 101.
Balancing the Risks and Benefits of Multidrug Regimens in the Clinical Management of Nontuberculous Mycobacterial Lung Disease.
Expert Insights in Diagnosis and Management of Common Drug-Induced Movement Disorders.
Classification Criteria for axSpA
Treatment Advances for RA
Management of NTM Lung Disease
Psoriatic Arthritis.
You Don't Know JAK in IBD.
Women With Psoriasis Are Struggling More Than Men
Presentation transcript:

Emerging Treatment Paradigms to Improve Quality of Life in Behçet Syndrome

Behçet Syndrome (BS) Overview

Prevalence of BS

Demographics of BS

Pathergy

Etiology of BS

Mucocutaneous Manifestations of BS

Skin Lesions

Genital Lesions

Oral Ulcers

Oral Ulcers (cont)

Differential Diagnosis Lichen Planus

Ocular Manifestations in BS

Other Manifestations in BS

Other Manifestations in BS (cont)

Diagnosing BS

ISG Criteria

Revised ICBD Criteria

Overview of Treatments for BS

2018 EULAR Recommendations in BS Overarching Principles

Colchicine

Topical Therapies for Oral Ulcers in BS

Apremilast for Treatment of Oral Ulcers in BS Randomized Phase 2 Study

Apremilast for Treatment of Oral Ulcers in BS Phase 2 Study Results

Apremilast for Treatment of Oral Ulcers in BS Randomized Phase 3 Study

Apremilast for Treatment of Oral Ulcers in BS Phase 3 Study Results

Apremilast for Refractory Oral/Genital Ulcers Open-Label Study

Etanercept for Treatment of Oral Ulcers in BS

2018 EULAR Recommendations for Ocular Disease in BS

Anti-TNF Agents in Ocular Disease in BS

IL Inhibitors

Concluding Remarks

Abbreviations